Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
29 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/29/3070486/0/en/Sandoz-enters-global-collaboration-license-agreement-with-Henlius-to-commercialize-leading-oncology-therapy-ipilimumab-in-multiple-indications.html
23 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/alligator-bioscience-announces-initiation-of-hlx22-phase-2-trial-in-breast-cancer-by-1018484
19 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/henlius-receives-orphan-drug-designation-for-innovative-anti-her2-mab-hlx22-in-the-us-for-gastric-cancer-302405856.html
07 Feb 2025
// PRESS RELEASE
https://www.drreddys.com/cms/cms/sites/default/files/2025-02/Dr.%20Reddy%27s%20PR%20-%20daratumumab%20FINAL.pdf
05 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/serplulimab-approved-in-the-eu-for-first-line-treatment-of-extensive-stage-small-cell-lung-cancer-es-sclc-302368903.html
23 Jan 2025
// PRESS RELEASE
ABOUT THIS PAGE